Safety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA^® Plus in Children and Adolescents

<b>Background:</b> With the emergence of SARS-CoV-2 Omicron sub-variants exhibiting increased transmissibility and immune escape, booster immunization is recommended. Ideally, vaccination across all age groups, including children and adolescents, is critical to control viral spread and reduce varian...

Полное описание

Библиографические подробности

Главные авторы:	Dagmar García-Rivera, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Rinaldo Puga-Gomez, Yariset Ricardo-Delgado, Carmen Valenzuela Silva, Sonsire Fernández-Castillo, Rocmira Pérez-Nicado, Laura Rodríguez-Noda, Darielys Santana-Mederos, Yanet Climent-Ruiz, Enrique Noa-Romero, Otto Cruz-Sui, Belinda Sánchez-Ramírez, Tays Hernández-García, Ariel Palenzuela-Diaz, Yury Valdés-Balbín, Vicente G. Vérez-Bencomo
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2025-11-01
Серии:	Vaccines
Предметы:	COVID-19 vaccine booster dose Omicron variant SOBERANA cross-neutralizing immunity
Online-ссылка:	https://www.mdpi.com/2076-393X/13/12/1198
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!